These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 262009)
1. [Side-effects of azathioprine and cyclophosphamide therapy]. Grgić Z Neurologija; 1979; 27(1-4):201-4. PubMed ID: 262009 [No Abstract] [Full Text] [Related]
2. High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies. Lin PT; Martin BA; Weinacker AB; So YT Muscle Nerve; 2006 Mar; 33(3):433-5. PubMed ID: 16116645 [TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive drug therapy in myasthenia gravis. Niakan E; Harati Y; Rolak LA Arch Neurol; 1986 Feb; 43(2):155-6. PubMed ID: 3947257 [TBL] [Abstract][Full Text] [Related]
4. Azathioprine as a single immunosuppressive drug in the treatment of myasthenia gravis. Cosi V; Lombardi M; Erbetta A; Piccolo G Acta Neurol (Napoli); 1993 Apr; 15(2):123-31. PubMed ID: 8328322 [TBL] [Abstract][Full Text] [Related]
5. [Immunosuppressive therapy of various autoimmune diseases of the nervous system]. Neretin VIa; Odinokova VA; Kir'iakov VA; Sapfirova VA Sov Med; 1990; (12):31-5. PubMed ID: 2097756 [No Abstract] [Full Text] [Related]
6. Azathioprine in the treatment of myasthenia gravis. Witte AS; Cornblath DR; Parry GJ; Lisak RP; Schatz NJ Ann Neurol; 1984 Jun; 15(6):602-5. PubMed ID: 6742794 [TBL] [Abstract][Full Text] [Related]
8. [Fluocortolon, azathioprine and cyclophosphamide in the therapy of myasthenia gravis]. Jusić A; Zagar M Neurologija; 1979; 27(1-4):167-79. PubMed ID: 400406 [No Abstract] [Full Text] [Related]
9. [Comments on the indication of immunosuppressive long-term therapy in myasthenia gravis (author's transl)]. Fasshauer K; Rath I Fortschr Neurol Psychiatr; 1981 Mar; 49(3):109-12. PubMed ID: 7227961 [No Abstract] [Full Text] [Related]
10. Portal hypertension secondary to azathioprine in myasthenia gravis. Fonseca V; Havard CW Postgrad Med J; 1988 Dec; 64(758):950-2. PubMed ID: 3256814 [TBL] [Abstract][Full Text] [Related]
11. Association of primary central nervous system lymphoma with long-term azathioprine therapy for myasthenia gravis? Herrlinger U; Weller M; Dichgans J; Melms A Ann Neurol; 2000 May; 47(5):682-3. PubMed ID: 10805346 [No Abstract] [Full Text] [Related]
12. [Treatment of myasthenia gravis by immunosuppressive non-steroidal drugs]. De Assis JL; Marchiori PE; Scaff M; Zambon AA Arq Neuropsiquiatr; 1986 Jun; 44(2):109-16. PubMed ID: 3800686 [TBL] [Abstract][Full Text] [Related]
13. Plasmapheresis as a guide for azathioprine therapy in prednisone-resistant myasthenia gravis. Rodnitzky RL; Bosch EP Muscle Nerve; 1981; 4(6):529-30. PubMed ID: 7311992 [No Abstract] [Full Text] [Related]
14. Low-dose azathioprine effectively suppresses clinical and immunological manifestations of generalized myasthenia. Finsterer J; Frank M; Krexner E South Med J; 2010 Feb; 103(2):182-4. PubMed ID: 20065912 [No Abstract] [Full Text] [Related]
15. Immunosuppressive drugs: azathioprine in the treatment of myasthenia gravis. Matell G Ann N Y Acad Sci; 1987; 505():589-94. PubMed ID: 3479940 [TBL] [Abstract][Full Text] [Related]
16. [Myelosuppression with macrocytic anaemia and leucopenia during treatment with azathioprine in myasthenia gravis]. Reinicke H; Weber FW; Hausamen TU Dtsch Med Wochenschr; 1982 Oct; 107(42):1592-4. PubMed ID: 7128472 [No Abstract] [Full Text] [Related]
17. Latent carcinoma of the prostate in a 24-year-old man receiving cyclophosphamide and azathioprine. Elliott GB; Silverberg DS; Dossetor JB; Muir CS Can Med Assoc J; 1977 Mar; 116(6):651-2. PubMed ID: 612349 [No Abstract] [Full Text] [Related]